Page last updated: 2024-08-24

triazoles and sufotidine

triazoles has been researched along with sufotidine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pounder, RE; Smith, JT1
Caputo, E; Mela, GS; Savarino, V; Villa, G; Zentilin, P1
Ernst, T; Gennoni, M; Halter, F; Merki, HS; Roehmel, JJ; Varga, L; Wilder-Smith, C; Zeyen, B1
Gavey, C; Nwokolo, CU; Pounder, RE; Smith, JT1
Holmfield, JH; Johnston, D; Primrose, JN; Rogers, MJ1
Humphray, JM; Reeves, JJ; Stables, R1
Johnston, DA; Wormsley, KG1
Higuchi, S; Isobe, Y; Kijima, H; Muramatsu, M; Suzuki, M; Yokomori, S1

Trials

5 trial(s) available for triazoles and sufotidine

ArticleYear
Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
    Gut, 1990, Volume: 31, Issue:3

    Topics: Adult; Circadian Rhythm; Double-Blind Method; Duodenal Ulcer; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Piperidines; Triazoles

1990
Loss of acid suppression during dosing with H2-receptor antagonists.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4 Suppl 1

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Electrodes; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Piperidines; Ranitidine; Triazoles

1990
Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4 Suppl 1

    Topics: Adult; Drug Tolerance; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Piperidines; Placebos; Ranitidine; Triazoles

1990
The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4 Suppl 1

    Topics: Adult; Double-Blind Method; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Piperidines; Triazoles

1990
Inhibition of gastric secretion following single morning or twice daily oral administration of sufotidine to volunteers.
    British journal of clinical pharmacology, 1989, Volume: 28, Issue:4

    Topics: Administration, Oral; Adult; Double-Blind Method; Esophagitis; Gastric Acid; Gastric Juice; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Pepsin A; Piperidines; Triazoles

1989

Other Studies

3 other study(ies) available for triazoles and sufotidine

ArticleYear
Intragastric acidity and serum gastrin after sufotidine.
    Gut, 1990, Volume: 31, Issue:9

    Topics: Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Piperidines; Triazoles

1990
Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4 Suppl 1

    Topics: Animals; Dogs; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Histamine; Histamine H2 Antagonists; Male; Mice; Mice, Inbred C57BL; Piperidines; Triazoles

1990
Structure-activity characterization of an H2-receptor antagonist, 3-amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-++ +butenylamino]- 3-cyclobutene-1,2-dione hydrochloride (T-066), involved in the insurmountable antagonism against histamine-induce
    Biochemical pharmacology, 1998, Jan-15, Volume: 55, Issue:2

    Topics: Animals; Guinea Pigs; Heart Atria; Heart Rate; Histamine; Histamine H2 Antagonists; In Vitro Techniques; Male; Molecular Structure; Piperidines; Pyridines; Structure-Activity Relationship; Triazoles

1998